Bayer introduces new anaemia assay:
This article was originally published in Clinica
German company Bayer has introduced CHr, an assay for monitoring the treatment of anaemia. The test measures haemoglobin in newly-produced red blood cells or reticulocytes. The assay will allow physicians to gain an immediate picture of functional iron status. The test can be used on Bayer's Technicon H3 haematology analysers and on the Advia 120 haematology system, which was unveiled in Rome last week (see this issue, p 11).
You may also be interested in...
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.